Does spirometry predict dyspnoea in advanced cancer?

Heyse-Moore, L.; Beynon, T.; Ross, V.
May 2000
Palliative Medicine;May2000, Vol. 14 Issue 3, p189
Academic Journal
This study explores the similarities and differences between subjective assessments of dyspnoea and objective spirometric indices of respiratory function in advanced cancer. Of 155 patients investigated, 71 (46%) were dyspnoeic and 108 (70%) had spirometry (94 post-salbutamol). Of the 94, 84 had height and weight measured to calculate predicted spirometry. Average dyspnoea levels over 24 h were measured by patient visual analogue scales (VASMe 24). Forced expiratory volume after 1 s (FEV1) and forced vital capacity (FVC) were almost always lower than predicted, indicating frequent impaired respiratory function. Mean spirometric increase post-salbutamol was 21% for FEV1 and 12% for FVC. Correlations between VAS dyspnoea scores and spirometry were low; hence, the latter cannot be relied upon as a measure of the former. Respiratory impairment tended to be obstructive (mean FEV1/FVC = 65%).


Related Articles

  • Spirometry Essentials for Medical Assistants Part I: The Rationale for Testing. Schulz, Neilsen J. // Journal of Continuing Education Topics & Issues;Jan2007, Vol. 9 Issue 1, p14 

    The article provides guidelines for medical assistants to conduct spirometry tests. Spontaneous dyspnea is a symptom of disease and requires diagnosis and medical follow-up. A case is presented involving a 67-year-old patient who has both healthy heart and lungs, but has a bleeding polyp in her...

  • HANDHELD SPIROMETRY AS A TOOL FOR GATHERING QUANTITATIVE RESEARCH DATA IN LUNG CANCER. Chernecky, Cynthia; Mayfield, William; Itkin, E. Lewis // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p470 

    Spirometry values (FEV-1, FVC and FEV-1/FVC%) have not been successful in differentiating values from normal subjects, COPD patients and all lung cancer patients combined. No studies have used handheld spirometry, in newly diagnosed and treatment naive patients with nonsmall- cell lung cancer...

  • Magic Words for Smoking Cessation -- Your Lungs Are 10 Years Older Than You Are. Scherger, Joseph E. // Internal Medicine Alert;5/15/2008 Pharmacology Watch, Vol. 30, preceding p66 

    Synopsis: In a British study telling the patient their lung age after spirometry doubled the likelihood of their stopping smoking at one year.

  • Selection of Pulmonary Resection Procedures to Avoid Postoperative Complications. Yoshinori Nagamatsu; Kanetaka Maeshiro; Masaki Kashihara; Yasunori Iwasaki; Ichirou Shima; Hideaki Yamana; Kazuo Shirouzu // Surgery Today;Mar2007, Vol. 37 Issue 3, p202 

    AbstractPurpose??We previously found a potential predictive value in a retrospective analysis of spirometry and an expired gas analysis during the exercise. We sought to reduce postoperative cardiopulmonary complications by selecting lung tumor resection procedures based on a combination of...

  • The Value of Spirometry in Clinical Practice Part 1. Martin, Lawrence // RT: The Journal for Respiratory Care Practitioners;Jun2010, Vol. 23 Issue 6, p14 

    The article presents the author's views on the value of spirometry as one of the fundamental tests in clinical medicine. He focuses on the four principal uses of spirometry which are to help in the diagnosis of patients who complain of dyspnea or chronic cough, differentiate asthma and chronic...

  • Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Thorn, Jörgen; Tilling, Björn; Lisspers, Karin; Jörgensen, Leif; Stenling, Anna; Stratelis, Georgios // Primary Care Respiratory Journal;Jun2012, Vol. 21 Issue 2, p159 

    Background: The importance of identifying chronic obstructive pulmonary disease (COPD) at an early stage is recognised. Improved and easily accessible identification of individuals at risk of COPD in primary care is needed to select patients for spirometry more accurately. Aims: To explore...

  • Spirometric Correlates of Dyspnea Improvement Among Emergency Department Patients With Chronic Obstructive Pulmonary Disease Exacerbation. Camargo Jr, Carlos A.; Chu-Lin Tsai; Clark, Sunday; Kenney, Patrick A.; Radeos, Michael S. // Respiratory Care;Jul2008, Vol. 53 Issue 7, p892 

    OBJECTIVE: To examine whether change in slow vital capacity (SVC) correlates to dyspnea improvement during emergency department (ED) treatment of chronic obstructive pulmonary disease (COPD) exacerbation. METHODS: We performed a prospective cohort study and enrolled consecutive patients during a...

  • COPD 'spippery slope' slowed by long-acting β2-agonists. Finch, Rob // Pulse;6/14/2004, Vol. 64 Issue 24, p16 

    Reports that patients with chronic obstructive pulmonary disease (COPD) can benefit from long-acting beta-2-agonists, even when their lung function appears to have declined irreversibly, according to research by William Man and colleagues at King's College Hospital in London, England. Reduction...

  • Smoking History and Bronchitis Symptoms Should Prompt a Spirometry Test for COPD. Marshall, Adriene // Pulmonary Reviews;Dec2008, Vol. 13 Issue 12, p1 

    The article focuses on a study which found that more than 25% of primary care patients with symptoms of chronic bronchitis and a long-standing history of smoking had undiagnosed chronic obstructive pulmonary disease (COPD). It was also found that 47% of study participants reported having slight...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics